Evidence-based Cardiology, Second Edition

Description

This second editionis a ground-breaking clinical text with a strong emphasis on rigorous evidence. Leaders in the field discuss best practice in the light of systematic reviews and randomised control trials, and how best to treat where the information is less clear. Case histories provide intriguing discussions on how to apply the evidence in real life situations.Evidence-based Cardiology also includes free access to the latest evidence, which is automatically posted on a companion website. Content: Chapter 1 What is Evidence?Based Cardiology? (pages 3–13): PJ Devereaux, R Brian Haynes and Salim YusufChapter 2 A Critical Appraisal of the Cardiovascular History and Physical Examination (pages 14–23): Akbar Panju, Brenda Hemmelgarn, Jim Nishikawa, Deborah Cook and Allan KitchingChapter 3 Obtaining Incremental Information from Diagnostic Tests (pages 24–33): Raymond J GibbonsChapter 4 Clinical Trials and Meta?Analysis (pages 34–39): Colin BaigentChapter 5 Finding Current Best Evidence to Practice Evidence?Based Cardiology (pages 40–45): Dereck L Hunt, K Ann McKibbon and R Brian HaynesChapter 6 Understanding Concepts Related to Health Economics (pages 46–55): Mark HlatkyChapter 7 Introduction to Decision Analysis (pages 56–70): Kevin A Schulman, Henry A Glick and Allan S DetskyChapter 8 Assessing and Changing Cardiovascular Clinical Practices (pages 71–88): C David Naylor and David A AlterChapter 9 Global Perspective on Cardiovascular Disease (pages 91–102): K Srinath ReddyChapter 10 Tobacco: Global Burden and Community Solutions (pages 103–113): Terry F Pechacek, Samira Asma, Nicole Blair and Michael P EriksenChapter 11 Tobacco and Cardiovascular Disease: Achieving Smoking Cessation (pages 114–120): Godfrey H FowlerChapter 12 Lipids and Cardiovascular Disease (pages 121–129): Malcolm LawChapter 13 Use of Lipid Lowering Agents in the Prevention of Cardiovascular Disease (pages 130–145): Jeffrey L ProbstfieldChapter 14 Blood Pressure and Cardiovascular Disease (pages 146–160): Curt D Furberg and Bruce M PsatyChapter 15 Glucose Abnormalities and Cardiovascular Disease: “Dysglycemia” as an Emerging Cardiovascular Risk Factor (pages 161–169): Sarah E Capes and Hertzel C GersteinChapter 16 Physical Activity and Exercise in Cardiovascular Disease Prevention and Rehabilitation (pages 170–180): Erika S Froelicher, Roberta K Oka and Gerald F FletcherChapter 17 Psychosocial Factors in the Primary and Secondary Prevention of Coronary Heart Disease: An Updated Systematic Review of Prospective Cohort Studies (pages 181–218): Harry Hemingway, Hannah Kuper and Michael MarmotChapter 18 Emerging Approaches in Cardiovascular Prevention (pages 219–230): Eva M Lonn, Marek Smieja and Salim YusufChapter 19 Obesity (pages 231–243): Arya M SharmaChapter 20 Postmenopausal Hormone Therapy and Cardiovascular Disease (pages 244–258): Jacques E RossouwChapter 21 Ethnicity and Cardiovascular Disease (pages 259–278): Sonia S Anand, Stephanie Ounpuu and Salim YusufChapter 22 The Fetal Origins of Coronary Heart Disease (pages 279–286): David JP BarkerChapter 23 Molecular Genetics of Cardiovascular Disorders (pages 287–299): AJ Marian and Robert RobertsChapter 24 Cost Effectiveness of Prevention of Cardiovascular Disease (pages 300–308): Daniel B MarkChapter 25 Diet and Cardiovascular Disease (pages 309–325): K Srinath ReddyChapter 26 Anti?Ischemic Drugs (pages 329–338): Lionel H OpieChapter 27 Impact of Revascularization Procedures in Chronic Coronary Artery Disease on Clinical Outcomes: A Critical Review of the Evidence (pages 339–359): Charanjit S Rihal, Dominic Raco, Bernard J Gersh and Salim YusufChapter 28 Adjunctive Medical Therapy in Percutaneous Coronary Intervention (pages 360–370): James L Velianou, Ronald R Van Der Wieken and Maarten M SimoonsChapter 29 Restenosis: Etiologies and Prevention (pages 371–394): Giuseppe Sangiorgi, David R Holmes and Robert S SchwartzChapter 30 Acute non?ST?segment Elevation Coronary Syndromes: Unstable Angina and non?ST?segment Elevation Myocardial Infarction (pages 397–425): Pierre Theroux and John A CairnsChapter 31 Fibrinolytic Therapy (pages 426–443): James S Zebrack and Jeffrey L AndersonChapter 32 Mechanical Reperfusion Strategies in Patients Presenting with Acute Myocardial Infarction (pages 444–455): Sanjaya Khanal and W Douglas WeaverChapter 33 Adjunctive Antithrombotic Therapy for St?Elevation Acute Myocardial Infarction (pages 456–476): John K French and Harvey D WhiteChapter 34 Pain Relief, General Management, and Other Adjunctive Treatments (pages 477–487): Aldo P Maggioni, Roberto Latini, Gianni Tognoni and Peter SleightChapter 35 Complications After Myocardial Infarction (pages 488–506): Peter L Thompson and Barry MckeownChapter 36 An Integrated Approach to the Management of Patients After the Early Phase of the Acute Coronary Syndromes (pages 507–516): Desmond G JulianChapter 37 Atrial Fibrillation: Antiarrhythmic Therapy (pages 519–547): Harry JGM Crijns, Isabelle C Van Gelder, Irina Savelieva and A John CammChapter 38 Atrial Fibrillation: Antithrombotic Therapy (pages 548–555): John A CairnsChapter 39 Atrial Fibrillation: Non?Pharmacologic Therapies (pages 556–566): Sanjeev Saksena and Andrew J EinsteinChapter 40 Supraventricular Tachycardia: Drugs v Ablation (pages 567–574): Neil R Grubb and Peter KoweyChapter 41 Prevention and Treatment of Life?Threatening Ventricular Arrhythmia and Sudden Death (pages 577–586): Eugene Crystal, Stuart J Connolly and Paul DorianChapter 42 Impact of Pacemakers: When and What Kind? (pages 587–618): William D Toff and A John CammChapter 43 Syncope (pages 619–633): David G Benditt, Cengiz Ermis, Keith G Lurie and Scott SakaguchiChapter 44 Cardiopulmonary Resuscitation (pages 634–640): Nicola E Schiebel and Roger D WhiteChapter 45 Prevention of Congestive Heart Failure and Treatment of Asymptomatic Left Ventricular Dysfunction (pages 643–658): RS Mckelvie, CR Benedict and Salim YusufChapter 46 Management of Overt Heart Failure (pages 659–680): Bert Andersson and Karl SwedbergChapter 47 Acute Myocarditis and Dilated Cardiomyopathy (pages 681–702): Barbara A Pisani and John F CarlquistChapter 48 Hypertrophic Cardiomyopathy (pages 703–717): Perry M Elliott, Rajesh Thaman and William J MckennaChapter 49 Other Cardiomyopathies (pages 718–732): Jose A Marin?Neto, Marcus ViniCius Simoes and Benedito Carlos MacielChapter 50 Pericardial Disease: An Evidence?Based Approach to Diagnosis and Treatment (pages 735–748): Bongani M Mayosi, James A Volmink and Patrick J CommerfordChapter 51 Rheumatic Heart Disease: Prevention and Acute Treatment (pages 751–757): Edmund AW Brice and Patrick J CommerfordChapter 52 Mitral Valve Disease: Indications for Surgery (pages 758–766): Blase A CarabelloChapter 53 Indications for Surgery in Aortic Valve Disease (pages 767–781): Heidi M Connolly and Shahbudin H RahimtoolaChapter 54 Balloon Valvuloplasty: Aortic Valve (pages 782–795): Daniel J Diver and Jeffrey A BreallChapter 55 Balloon Valvuloplasty: Mitral Valve (pages 796–808): Zoltan G TuriChapter 56 Valve Repair and Choice of Valves (pages 809–816): Paul J Pearson and Hartzell V SchaffChapter 57 Diagnosis and Management of Infective Endocarditis (pages 817–831): David T Durack and Michael L TownsChapter 58 Antithrombotic Therapy after Heart Valve Replacement (pages 832–836): Alexander GG Turpie and Walter AgenoChapter 59 Treatment of Patients with Stroke (pages 839–852): Craig S AndersonChapter 60 Heart Disease and Pregnancy (pages 853–863): Samuel C Siu and Jack M ColmanChapter 61 Venous Thromboembolic Disease (pages 864–876): Clive Kearon, Jeffrey S Ginsberg and Jack HirshChapter 62 Peripheral Vascular Disease (pages 877–886): Jesper Swedenborg and Jan OstergrenChapter 63 Clinical Applications of External Evidence (pages 889–891): Ernest L Fallen and Salim YusufChapter 64 Stable Angina: Choice of PCI v CABG v Drugs (pages 892–895): Douglas A HolderChapter 65 Acute Coronary Syndromes (pages 896–901): George J PhilippidesChapter 66 Acute Myocardial Infarction (pages 902–905): Bryan F Dias and Ernest L FallenChapter 67 Postmyocardial Infarction: Preventive Measures (pages 906–908): Ernest L FallenChapter 68 Metabolic Risk and Secondary Prevention of Coronary Disease (pages 909–911): Jacques GenestChapter 69 Peripheral Vascular Disease with Suspect Coronary Artery Disease (pages 912–914): Peter C SpittellChapter 70 Heart Failure (pages 915–920): Michael M GivertzChapter 71 Atrial Fibrillation (pages 921–924): Michael KleinChapter 72 Ventricular Dysrhythmias: Pharmacologic v Non?Pharmacologic Treatment (pages 925–930): L Brent MitchellChapter 73 Bradyarrhythmias: Choice of Pacemaker (pages 931–933): John A BooneChapter 74 Valvular Heart Disease: Timing of Surgery (pages 934–937): Adrian P Banning and Brian B Gribbin